Conventional and Alternative Pain Treatment Market Research 2024-2029, Profiles of Market Leaders - Medtronic, Abbott, GSK, Pfizer Inc., and Johnson & Johnson - ResearchAndMarkets.com

The "Conventional and Alternative Pain Treatment Market" report has been added to ResearchAndMarkets.com's offering.

The Conventional and Alternative Pain Treatment Market was valued at USD 96.2 billion in 2024, and is projected to reach USD 144.2 billion by 2029, rising at a CAGR of 8.40%.

This report covers the conventional and alternative pain treatments used by patients with chronic or acute pain. It provides the current and future market potential of conventional and alternative pain treatments and includes a detailed analysis of the competitive environment. The report covers the drivers, restraints and opportunities in the market; surveys the prevalence of or incidence of chronic diseases; and highlights emerging technologies for alternative treatment procedures. It includes market projections for 2029 and provides the market shares of key players.

The devices segment, which held a 36.6% share of the overall market in 2023, is expected to grow at a CAGR of 6.7%. The growth rate of this segment is attributed to factors such as the robust use of transcutaneous electrical nerve stimulation (TENS), spine stimulators and other electric impulse devices in North America, Europe, Latin America, the Middle East and most of the developed countries within the Asia-Pacific and Africa. The growth of the conventional and alternative pain treatment market can also be attributed to the growing number of physical procedures being performed in clinics and rehabs. The rise in demand for new drugs, cannabis drugs and other alternative devices is likely to drive the market.

In this analysis, the conventional and alternative pain treatment market is segmented based on pain management type into pharmaceuticals/drug therapy and devices. The pharmaceuticals/drug therapy segment is further segmented into non-narcotic analgesics, medical cannabis, narcotic analgesics, antimigraine agents, central nervous system (CNS) treatments, anesthetics, and other classes of pharmaceutical drug therapy.

The devices segment of the conventional and alternative pain treatment market is further segmented into spine stimulators, electrotherapy/muscle stimulation, and other devices. Based on application, the overall conventional and alternative pain treatment market is segmented into orthopedic and musculoskeletal pain, general and broad pain management, surgical pain management, migraine/headache pain, neuropathic pain, cancer pain, fibromyalgia pain, and other pain types.

The overall conventional and alternative pain treatment market has also been segmented by geography into North America, Europe, Asia-Pacific, Latin America and Middle East & Africa (MEA). Each regional analysis covers the region's leading countries, namely, the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico and GCC countries. Market data is provided for 2023, which serves as the base year; estimates are given for 2024 and forecast values for 2029.

The report includes:

• 48 data tables and 56 additional tables
• Analysis of the global market for conventional and alternative pain treatments
• Analyses of global market trends, with market revenue data from 2012-2023, estimates for 2024, and projected CAGRs through 2029
• Estimate of the current market size and revenue prospects of the global market, along with a market share analysis by pain management type, application and region
• Facts and figures pertaining to the market dynamics, technological advances, regulations, and the influence of macroeconomic factors
• A Porter's Five Forces analysis, a global supply chain analysis and a SWOT analysis
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, ESG score analysis, and the ESG practices of leading companies
• A look at recent patent grants
• Analysis of the industry structure and competitive landscape, including company market shares, strategic alliances, M&A activity and venture funding outlook
• Profiles of market leaders, including: Medtronic, Abbott, GSK, Pfizer Inc., and Johnson & Johnson

Company Profiles

• Abbott
• AbbVie Inc.
• Amgen Inc.
• Baxter
• Bayer AG
• Boehringer Ingelheim International GmbH
• Boston Scientific Corp.
• GSK PLC
• Johnson & Johnson Services Inc.
• Lilly
• Medtronic
• Merck & Co. Inc.
• Novartis AG
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.

Key Attributes:

Key Topics Covered:

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview of Types of Pain and Its Treatment

• Introduction
• The Perception of Pain
• How Pain is Treated
• Pain Management Techniques: Electrical Stimulation
• Pain Management Procedures
• Alternative Methods of Pain Management
• Growing Trend in Cannabis Treatment for Pain
• Treatment Using Alternatives for Chronic Pain

Chapter 3 Market Dynamics

• Introduction
• Market Drivers
• Rise in the Aging Population
• Increasing Integration of Artificial Intelligence in Medical Devices
• Rising Incidence of Chronic Diseases
• Growth of Public Health Programs That Address Chronic Pain
• Improvement in the Non-Drug Techniques
• Market Restraints
• Failure in Medical Device Designs
• Supply Chain Issues and Quality Concerns
• Market Opportunities
• Expanding Usage of Wearable Devices
• Technological Development for Conventional and Alternative Pain Treatment
• Future Trends and Possibilities

Chapter 4 Emerging Technologies and Developments

• Introduction
• Regenerative Medicine
• Advantages of Regenerative Pain Management
• Minuteman Procedure
• Peripheral Nerve Stimulation (PNS)
• VIA Disc Treatment
• Other Technologies
• Wearable Devices and Biofeedback
• Virtual Reality (VR) Therapy
• Artificial Intelligence (AI) in Pain Prediction
• Pain Management Clinical Trials
• Trends in Development of Conventional and Alternative Pain Treatment

Chapter 5 Market Segmentation Analysis

• Segmentation Breakdown
• Market Breakdown by Pain Management Type
• Market Size and Forecast
• Pharmaceuticals/Drug Therapy
• Market Size and Forecast
• Non-Narcotic Analgesics
• Medical Cannabis
• Narcotic Analgesics
• Antimigraine Agents
• Central Nervous System (CNS) Treatments
• Anesthetics
• Other Classes
• Devices
• Market Size and Forecast
• Spine Stimulators
• Electrotherapy/Muscle Stimulation
• Other Devices
• Market Breakdown by Application
• Orthopedic and Musculoskeletal Pain
• General and Broad Pain Management
• Surgical Pain Management
• Migraine/Headache
• Neuropathic Pain
• Cancer Pain
• Fibromyalgia Pain
• Other Pain Types
• Geographical Breakdown

Chapter 6 Competitive Intelligence

• Introduction
• Global Analysis of the Market and Its Leading Players
• Agreements, Collaborations and Partnerships
• 2023 Device Approvals

Chapter 7 Sustainability

• Importance of ESG in the Conventional and Alternative Pain Treatment Industry
• ESG Practices in the Pain Treatment Medical Device Industry
• Environmental Performance
• Social Performance
• Governance Performance
• ESG Ranking
• BCC Research Viewpoint

Chapter 8 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/sblksn

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250103965508/en/